Title : Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study.

Pub. Date : 2022 Mar 22

PMID : 35448150






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 c-MYC and/or HER-2 amplified oesophageal cancer models have demonstrated sensitivity to BTK inhibition with ibrutinib. ibrutinib Bruton tyrosine kinase Homo sapiens